Robert Mark Weisbrod

Based at Boston University, Robert Mark Weisbrod focuses their scholarly efforts on nitric oxide, endothelin, atherosclerosis, peripheral artery disease, endothelial dysfunction, vascular biology, cardiovascular risk, e-cigarettes, bridging the gap between theory and practice in nitric oxide. A representative example of their recent contribution is the study titled "Coronary Microvascular Function Following Severe Preeclampsia", which offers critical insights into the dynamics of nitric oxide and endothelin. Additional work such as "miR-369-3p ameliorates diabetes-associated atherosclerosis by regulating macrophage succinate-GPR91 signalling" further demonstrates their commitment to advancing knowledge in this domain.